Welcome to computational protein drug design.
ProteinQure is a computational company focused on the design of novel exotic peptides with therapeutic applications. We have developed ProteinStudio an integrated platform of proprietary technologies and core capabilities to solve complex drug design challenges. Platform validation has been proven (including multiple times in-vivo) via the development of an internal pipeline of maturing assets for tissue specific delivery as well as via external partnerships.
Computer generated scaffolds, 1000s of commercially available NCAAs and high quality assays means we can now design unprecedented drug-like peptides with small amounts of data.
Despite their inherent advantages, it is very difficult to design protein-based therapeutics.
Computational tools have been previously held back because of proteins' larger size and the lack of available structural data.
We leverage physics-based methods and novel machine learning algorithms to overcome these challenges.
By choosing tissue-restricted targets which undergo internalization, we ensure that the therapeutic payload is going to the right cells. Their small size also enhances tissue penetration.
Peptides can be engineered to be non-immunogenic by design, we can also achieve an unprecedented range of necessary PK profiles.
Peptide conjugates are much easier to manufacture. Novel chemistries allow for a wide range of conjugations and they can succeed in many routes of administration.
We are located in downtown Toronto; one of the fastest growing tech hubs in North America. At the heart of the university and life sciences ecosystems, we benefit from great relationships with the surrounding players in AI and biotech.
Interested in learning more? Come talk to us!
Office Address: 119 Spadina Ave Suite 304, Toronto, ON M5V 2L1, Canada
E-Mail: team@proteinqure.com
Web: www.proteinqure.com
Show Google Map